Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Review · April 23, 2024

Type 2 Diabetes and Cardiometabolic Outcomes in Metabolic Dysfunction–Associated Steatotic Liver Disease

Diabetes Research and Clinical Practice


Additional Info

Diabetes Research and Clinical Practice
Type 2 diabetes mellitus and cardiometabolic outcomes in metabolic dysfunction-associated steatotic liver disease population
Diabetes Res. Clin. Pract. 2024 Apr 02;[EPub Ahead of Print], NWS Chew, X Hui Pan, B Chong, C Chandramouli, M Muthiah, CSP Lam

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading